Daniel Mark Wechsler's Net Worth

-$250 Thousand

Estimate Recalculated Sep 9, 2024 03:55PM EST

Who is Daniel Mark Wechsler?

Daniel Mark Wechsler does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Valeant Pharmaceuticals International, Inc., and MELINTA THERAPEUTICS, INC. /NEW/.

SEC CIK

Daniel Mark Wechsler's CIK is 0001582285

Past Insider Trading and Trends

2013 was Daniel Mark Wechsler's most active year for acquiring shares with 2 total transactions. Daniel Mark Wechsler's most active month to acquire stocks was the month of July. 2018 saw Daniel Mark Wechsler paying a total of $250,000.00 for 200,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Valeant Pharmaceuticals International, Inc. (BHC) Snapshot price: $6.1229

EVO, Co. Grp. Chmn, Eye Health

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 12
Form 3
—
0
—
—
0
No matching records found

MELINTA THERAPEUTICS, INC. /NEW/ No price found

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 12
Form 4
∞
50K
$5.00
$250,000.00
50K
May 29
Form 4
—
0
—
—
0
Nov 3
Form 3
—
0
—
—
0
No matching records found